SCHOLAR ROCK, INC. logo

SCHOLAR ROCK, INC.

17 Marks
Corp.
First Filed:Sep 26, 2012Latest Filed:Feb 11, 2026Address:301 Binney Street, 3rd Floor, Cambridge, MA 02142

Portfolio Overview

Registered
3(18%)
Pending
12(71%)
Dead
2(12%)

Top Classes

Class 5
Pharmaceuticals
11(65%)
Class 42
Software, IT Services & Scientific Research
6(35%)
Class 44
Medical, beauty and agricultural services
5(29%)

TTAB Proceedings

Total Proceedings
1
As Plaintiff
1(100%)
As Defendant
0(0%)

Top Firms

Wolf, Greenfield & Sacks, P....(Jan 2026)
15

Trademark Activity Timeline(2012 – 2026)

Trademark Portfolio

17 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
SCHOLAR ROCK SUPPORTS
SCHOLAR ROCK SUPPORTS
Service Mark
Word
ITU
PENDING
Owner:
Serial:99646785
Filed:Feb 11, 2026
Classes:41, 44, 45
Goods & Services
Class 041: Patient and caregiver support services, namely, providing patient and caregiver education, namely, classes, lecture presentations, and online webinars on the subjects of spinal muscular atrophy and apitegromab preparations; Class 044: Patient and caregiver support services, namely, providing medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, and drug access; Class 045: Patient and caregiver support services, namely, providing case management services, namely, coordinating the procurement and administration of medication
MYO360
MYO360
Trademark
Word
PENDING
Owner:
Serial:99584458
Filed:Jan 8, 2026
Classes:N/A
SCHOLAR ROCK CONNECTS
SCHOLAR ROCK CONNECTS
Service Mark
Word
ITU
PENDING
Owner:
Serial:99579669
Filed:Jan 6, 2026
Classes:41, 44, 45
Goods & Services
Class 041: Patient and caregiver support services, namely, providing patient and caregiver education, namely, classes, lecture presentations, and online webinars on the subjects of spinal muscular atrophy and apitegromab preparations; Class 044: Patient and caregiver support services, namely, providing medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, and drug access; Class 045: Patient and caregiver support services, namely, providing case management services, namely, coordinating the procurement and administration of medication
ISEMBYLD
ISEMBYLD
Trademark
Combined
ITU
PENDING
Owner:
Serial:99208503
Filed:May 29, 2025
Classes:5, 42, 44
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; patient and caregiver support services and medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, case management, financial assistance, copay support, reimbursement support, drug access, patient and caregiver education, and support for infusions and infusion logistics; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
ISEMBYLD CONNECT
ISEMBYLD CONNECT
Service Mark
Word
ABANDONED
Owner:
Serial:99208493
Filed:May 29, 2025
Classes:44
Goods & Services
patient and caregiver support services and medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, case management, financial assistance, copay support, reimbursement support, drug access, patient and caregiver education, and support for infusions and infusion logistics
M
M
Trademark
Combined
ITU
PENDING
Owner:
Serial:99208514
Filed:May 29, 2025
Classes:5, 42, 44
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; patient and caregiver support services and medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, case management, financial assistance, copay support, reimbursement support, drug access, patient and caregiver education, and support for infusions and infusion logistics; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
99017289
99017289
Trademark
Design
ITU
PENDING
Owner:
Serial:99017289
Filed:Jan 24, 2025
Classes:5, 42
Goods & Services
therapeutic agents for the diagnosis, treatment and prevention of diseases and disorders, namely, neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; therapeutic antibodies for the diagnosis, treatment and prevention of neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; pharmaceutical preparations for the diagnosis, treatment and prevention of neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
99017270
99017270
Trademark
Design
ITU
PENDING
Owner:
Serial:99017270
Filed:Jan 24, 2025
Classes:5, 42
Goods & Services
Therapeutic agents for the diagnosis, treatment and prevention of diseases and disorders, namely, neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; therapeutic antibodies for the diagnosis, treatment and prevention of neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; pharmaceutical preparations for the diagnosis, treatment and prevention of neuromuscular, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
BILDSKYRO
BILDSKYRO
Trademark
Word
ITU
PENDING
Owner:
Serial:97774701
Filed:Jan 31, 2023
Classes:5
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
MYOHTII
MYOHTII
Trademark
Word
ITU
PENDING
Owner:
Serial:97774696
Filed:Jan 31, 2023
Classes:5
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
ISEMBYLD
ISEMBYLD
Trademark
Word
ITU
PENDING
Owner:
Serial:97723538
Filed:Dec 19, 2022
Classes:5
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
ISYMBILD
ISYMBILD
Trademark
Word
ITU
PENDING
Owner:
Serial:97723549
Filed:Dec 19, 2022
Classes:5
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
WAYMYO
WAYMYO
Trademark
Word
ITU
PENDING
Owner:
Serial:97723555
Filed:Dec 19, 2022
Classes:5
Goods & Services
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
SCHOLAR ROCK
SCHOLAR ROCK
Trademark
Combined
REGISTERED
Owner:
Serial:88692504
Filed:Nov 14, 2019
Classes:5
Registration:7043356
Registered:May 2, 2023
Goods & Services
therapeutic agents for the diagnosis, treatment and prevention of diseases and disorders, namely, fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; therapeutic antibodies for the diagnosis, treatment and prevention of fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias; pharmaceutical preparations for the diagnosis, treatment and prevention of fibrosis, autoimmune diseases, cancers, diseases of metabolism, musculoskeletal disorders, anemias | research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
SUPRACELLULAR ACTIVATION
SUPRACELLULAR ACTIVATION
Service Mark
Word
ABANDONED
Owner:
Serial:86866693
Filed:Jan 6, 2016
Classes:42
SCHOLAR ROCK
SCHOLAR ROCK
Service Mark
Word
REGISTERED
Owner:
Serial:85983370
Filed:Sep 26, 2012
Classes:42
Registration:4700587
Registered:Mar 10, 2015
Goods & Services
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic [ and diagnostic ] products
SCHOLAR ROCK
SCHOLAR ROCK
Trademark
Word
REGISTERED
Owner:
Serial:85738940
Filed:Sep 26, 2012
Classes:5
Registration:4748345
Registered:Jun 2, 2015
Goods & Services
Therapeutic agents for the diagnosis, treatment and prevention of diseases and disorders, namely, fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders; therapeutic antibodies for the diagnosis, treatment and prevention of fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders; pharmaceutical preparations for the diagnosis, treatment and prevention of fibrosis, autoimmune disease, cancer, diseases of metabolism, and musculoskeletal disorders

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy